Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Carisma Therapeutics Inc. buy melinda

Carisma Therapeutics Inc.

Start price

€34.10

/ 50%

Target price

21.08.20

Performance (%)

End price

€18.58

Summary

This prediction ended on with a price of €18.58. Massive losses of were the result for the BUY prediction by melinda. melinda has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Carisma Therapeutics Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

According to melinda what are the pros and cons of Carisma Therapeutics Inc. for the foreseeable future?

Pros

Could be worthwhile Investment >10% per year

Cons

Comments by melinda for this prediction

In the thread Sesen Bio Inc diskutieren

Prediction Buy

Perf. (%)

Target price 2.255

Change

Ends at

Secteur Recherche biotechnologique et médicale Agenda 13/05 Publication de résultats

Sesen Bio, Inc, anciennement Eleven Biotherapeutics, Inc, une société clinique en phase terminale qui fournit une plate-forme de thérapie protéique ciblée (TPT). Société se concentrant sur le développement des anticorps-médicaments conjugués (ADC) pour le traitement du cancer. Son portefeuille de produits comprend Vicinium, Vicinium en combinaison avec un inhibiteur de contrôle de contrôle, durvalumab et VB6-845d. Le programe principal de la Société, Vicinium, ainsi que la poursuite de la phase III de développement du traitement du cancer de la vessie non invasive et non musculaire (NMIBC).Les cibles antigènes de la molécule d'adhésion des cellules épithéliales (EpCAM) dans la cellule tumorale pour libérer une cytotoxine puissante, les exotoxines A de Pseudomonas (ETA), directement aux cellules cancéreuses.

Nombre d'employés

: 17 personnes.

0

In the thread Trading Sesen Bio Inc

Prediction Buy

Perf. (%)

Target price 2.255

Change

Ends at

Buy beendet

0

Stopped prediction by melinda for Carisma Therapeutics Inc.

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€16.58

16.10.22

Could be worthwhile Investment >10% per year

0%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.028

16.10.22

-

Could be worthwhile Investment >10% per year

0%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.028

16.10.22

-

Could be worthwhile Investment >10% per year

0%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.028

16.10.22

-

Could be worthwhile Investment >10% per year

40%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€15.44

12.10.22

Could be worthwhile Investment >10% per year

0%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€73.80

17.06.22

Could be worthwhile Investment >10% per year

50%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€18.58

04.11.21

Could be worthwhile Investment >10% per year

50%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€22.73

20.05.19

Could be worthwhile Investment >10% per year

50%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€26.34

07.11.18

Could be worthwhile Investment >10% per year

50%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€13.35

03.01.18

Could be worthwhile Investment >10% per year

50%

Carisma Therapeutics Inc.

Start price

Target price

Perf. (%)

€47.45

25.07.16

Could be worthwhile Investment >10% per year

50%